Study: 26% of C. Diff Patients Received Only Unnecessary Antimicrobials
Infection Control and Hospital Epidemiology.
Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
Patient safety tool: AHIMA, AHDI's QA program implementation resource kitRead Now
- 4 ASCs with effective purchasing strategies
- Temple University School of Medicine appoints Dr. Marshall Ki Lee assistant professor of anesthesiology
- California set to pass standards bill for surgical technicians
- 4 strategies for adapting your team to change
- 4 questions to ask about managed care before joint-venturing